Open access
Oct 2026
FZD7 drives retinal ferroptosis in diabetic retinopathy via β-catenin-dependent suppression of the DHODH/FSP1 axis.
Inhibition of FZD7 restores endogenous anti-ferroptotic mechanisms and confers retinal protection, establishing FZD7 as a previously unrecognized therapeutic target for diabetic retinopathy.
Jiaojiao Jiang, Liu Zheng, Lu Wang et al.
· Journal of Pharmacological S... · 0 citations